Article(id=1329905931158139844, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905930747098051, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2025.10.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1741104000000, receivedDateStr=2025-03-05, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795003882444, onlineDateStr=2026-11-18, pubDate=1760025600000, pubDateStr=2025-10-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795003882444, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795003882444, creator=13701087609, updateTime=1795003882444, updator=13701087609, issue=Issue{id=1329905930747098051, tenantId=1146029695717560320, journalId=1319690259887390882, year='2025', volume='56', issue='10', pageStart='1243', pageEnd='1370', issueExtLink='null', onlineDate='null', pubDate='1760025600000', pubDateStr='2025-10-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=0, createTime=1795003882347, creator='13701087609', updateTime=1795004334384, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329907827268760040, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905930747098051, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329907827268760041, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905930747098051, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1243, endPage=1251, ext={EN=ArticleExt(id=1329905931388826565, articleId=1329905931158139844, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Research Progress of Antibody Drug Conjugates, columnId=1325194059773522066, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspectives & Review, runingTitle=null, highlight=null, articleAbstract=

Antibody-drug conjugates(ADCs) are novel antineoplastics that combine the high targeting specificity of monoclonal antibodies with the potent cytotoxicity of small-molecule toxins. By selectively delivering cytotoxic payloads to tumor cells, ADCs achieve effective tumor cell killing while minimizing damage to healthy cells and reducing systemic toxicity. These innovative agents, often referred to as “biological missile”, are leading a new era in targeted cancer therapy.Although three generations of ADCs have been applied to cancer treatment, further optimization of the components of ADCs is still required to address challenges such as stability, cytotoxicity, and drug resistance. This article summarizes the approved ADCs and those under clinical research, outlines innovative directions for next-generation ADCs, to provide insights for advancing research and development of novel cancer treatments using ADC technology.

, authors=Lili ZHAO1, 2, Yuqiang ZHU1, 2, Peng LI1, 2, Zhongsong ZHU1, 2, Zhong LIU3, *, authorsList=Lili ZHAO, Yuqiang ZHU, Peng LI, Zhongsong ZHU, Zhong LIU, authorCompany=null, correspAuthors=Zhong LIU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329905931661456326, articleId=1329905931158139844, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=抗体偶联药物的研究进展, columnId=1322624444544176331, journalTitle=中国医药工业杂志, columnName=专论与综述, runingTitle=null, highlight=null, articleAbstract=

抗体偶联药物(ADCs)是结合了单克隆抗体的高度靶向性和小分子毒素的强细胞毒性的新型抗肿瘤药,能在高效杀伤肿瘤细胞的同时,最大限度地减少对健康细胞的损伤并降低全身毒性。这种被称为“生物导弹”的新型抗肿瘤药正在引领恶性肿瘤靶向治疗的新时代。虽然已有三代ADCs应用于恶性肿瘤治疗,但仍需要进一步优化ADCs各组分来解决ADCs的稳定性、细胞毒性、耐药性等问题。本文总结了已获批上市和临床在研的ADCs,展望了下一代ADCs的创新方向,为利用ADCs技术推进恶性肿瘤的治疗和研究提供了思路。

, authors=赵丽丽1, 2, 朱玉强1, 2, 李朋1, 2, 朱中松1, 2, 刘忠3, *, authorsList=赵丽丽, 朱玉强, 李朋, 朱中松, 刘忠, authorCompany=null, correspAuthors=刘忠, authorNote=

赵丽丽,博士,高级研究员,从事蛋白药物的研究与开发。

, correspAuthorsNote=
刘忠,博士,高级研究员,从事蛋白药物的研究与开发。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=4Jai2bvzEuEMuaIhtxZTbA==, magXml=5yH5gEJH+Ux+uw2i0x3ZHQ==, pdfUrl=null, pdf=CgBOv2lpa6delpILobrpnQ==, pdfFileSize=1353068, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=ucepVBqa1NqAJ6vKkdu/3g==, mapNumber=null, fund=null)}, authors=[Author(id=1329905932198327249, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905932307379156, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932198327249, language=EN, stringName=Lili ZHAO, firstName=Lili, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400
2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905932391265237, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932198327249, language=CN, stringName=赵丽丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.鲁南新时代生物技术有限公司,山东 临沂 273400
2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400, bio={"content":"

赵丽丽,博士,高级研究员,从事蛋白药物的研究与开发。

"}, bioImg=null, bioContent=

赵丽丽,博士,高级研究员,从事蛋白药物的研究与开发。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905931900531655, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=1., ext=[AuthorCompanyExt(id=1329905931913114568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905931925697481, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南新时代生物技术有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905931988612042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=2., ext=[AuthorCompanyExt(id=1329905931997000651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905932009583564, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)])]), Author(id=1329905932458374103, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905932529677274, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932458374103, language=EN, stringName=Yuqiang ZHU, firstName=Yuqiang, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400
2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905932600980443, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932458374103, language=CN, stringName=朱玉强, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.鲁南新时代生物技术有限公司,山东 临沂 273400
2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905931900531655, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=1., ext=[AuthorCompanyExt(id=1329905931913114568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905931925697481, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南新时代生物技术有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905931988612042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=2., ext=[AuthorCompanyExt(id=1329905931997000651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905932009583564, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)])]), Author(id=1329905932672283613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905932756169696, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932672283613, language=EN, stringName=Peng LI, firstName=Peng, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400
2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905932823278561, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932672283613, language=CN, stringName=李朋, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.鲁南新时代生物技术有限公司,山东 临沂 273400
2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905931900531655, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=1., ext=[AuthorCompanyExt(id=1329905931913114568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905931925697481, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南新时代生物技术有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905931988612042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=2., ext=[AuthorCompanyExt(id=1329905931997000651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905932009583564, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)])]), Author(id=1329905932886193123, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905932961690598, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932886193123, language=EN, stringName=Zhongsong ZHU, firstName=Zhongsong, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400
2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905933024605159, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932886193123, language=CN, stringName=朱中松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.鲁南新时代生物技术有限公司,山东 临沂 273400
2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905931900531655, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=1., ext=[AuthorCompanyExt(id=1329905931913114568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905931925697481, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南新时代生物技术有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905931988612042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=2., ext=[AuthorCompanyExt(id=1329905931997000651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905932009583564, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)])]), Author(id=1329905933087519721, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329905933163017195, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905933087519721, language=EN, stringName=Zhong LIU, firstName=Zhong, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905933234320364, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905933087519721, language=CN, stringName=刘忠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.鲁南制药集团股份有限公司,山东 临沂 276000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905932110246861, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=3., ext=[AuthorCompanyExt(id=1329905932122829774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905932110246861, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000), AuthorCompanyExt(id=1329905932131218383, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905932110246861, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.鲁南制药集团股份有限公司,山东 临沂 276000)])])], keywords=[Keyword(id=1329905933322400749, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, language=EN, orderNo=1, keyword=antineoplastics), Keyword(id=1329905933385315310, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, language=EN, orderNo=2, keyword=antibody-drug conjugate), Keyword(id=1329905933448229871, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, language=EN, orderNo=3, keyword=frontier technology), Keyword(id=1329905933511144432, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, language=EN, orderNo=4, keyword=stability), Keyword(id=1329905933578253297, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, language=EN, orderNo=5, keyword=cytotoxicity), Keyword(id=1329905933636973554, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, language=EN, orderNo=6, keyword=drug resistance), Keyword(id=1329905933704082419, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, language=EN, orderNo=7, keyword=research progress), Keyword(id=1329905933766996980, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, language=CN, orderNo=1, keyword=抗肿瘤药), Keyword(id=1329905933842494453, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, language=CN, orderNo=2, keyword=抗体偶联药物), Keyword(id=1329905933943157750, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, language=CN, orderNo=3, keyword=前沿技术), Keyword(id=1329905934006072311, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, language=CN, orderNo=4, keyword=稳定性), Keyword(id=1329905934073181176, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, language=CN, orderNo=5, keyword=细胞毒性), Keyword(id=1329905934148678649, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, language=CN, orderNo=6, keyword=耐药性), Keyword(id=1329905934215787514, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, language=CN, orderNo=7, keyword=研究进展)], refs=[Reference(id=1329905934421308412, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=BAAH S, LAWS M, RAHMAN K M.Antibody-drug conjugates - a tutorial review [J].Molecules, 2021, 26(10): 2943., articleTitle=null, refAbstract=null), Reference(id=1329905934526166013, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=MCKERTISH C M, KAYSER V.Advances and limitations of antibody drug conjugates for cancer [J].Biomedicines,2021, 9(8): 872., articleTitle=null, refAbstract=null), Reference(id=1329905934635217918, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=TSUCHIKAMA K, AN Z Q.Antibody-drug conjugates: recent advances in conjugation and linker chemistries [J].Protein Cell, 2018, 9(1): 33-46., articleTitle=null, refAbstract=null), Reference(id=1329905934706521087, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=JOHNSTON M C, SCOTT C J.Antibody conjugated nanoparticles as a novel form of antibody drug conjugate chemotherapy [J].Drug Discov Today Technol, 2018, 30: 63-69., articleTitle=null, refAbstract=null), Reference(id=1329905934773629952, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=BECK A, GOETSCH L, DUMONTET C, et al.Strategies and challenges for the next generation of antibody-drug conjugates [J].Nat Rev Drug Discov, 2017, 16(5): 315-337., articleTitle=null, refAbstract=null), Reference(id=1329905934836543488, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=BLACKHALL F, JAO K, GREILLIER L, et al.Efficacy and safety of rovalpituzumab tesirine compared with topotecan as second-line therapy in DLL3-high SCLC: results from the phase 3 TAHOE study [J].J Thorac Oncol, 2021, 16(9): 1547-1558., articleTitle=null, refAbstract=null), Reference(id=1329905934903652353, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=LI J H, LIU L, ZHAO X H.Precision targeting in oncology: the future of conjugated drugs [J].Biomed Pharmacother,2024, 177: 117106., articleTitle=null, refAbstract=null), Reference(id=1329905935000121346, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=HOFFMANN R M, COUMBE B G T, JOSEPHS D H, et al.Antibody structure and engineering considerations for the design and function of antibody drug conjugates [J].Oncoimmunology, 2018, 7(3): e1395127., articleTitle=null, refAbstract=null), Reference(id=1329905935063035907, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=MAREI H E, CENCIARELLI C, HASAN A.Potential of antibody-drug conjugates(ADCs) for cancer therapy [J].Cancer Cell Int, 2022, 22(1): 255., articleTitle=null, refAbstract=null), Reference(id=1329905935125950468, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=RUAN D Y, WU H X, MENG Q, et al.Development of antibody-drug conjugates in cancer: overview and prospects[J].Cancer Commun (Lond), 2024, 44(1): 3-22., articleTitle=null, refAbstract=null), Reference(id=1329905935184670725, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU Y T, NGUYEN A W, MAYNARD J A.Engineering antibodies for conditional activity in the solid tumor microenvironment [J].Curr Opin Biotechnol, 2022, 78: 102809., articleTitle=null, refAbstract=null), Reference(id=1329905935247585286, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=GONG L M, ZHAO H M, LIU Y H, et al.Research advances in peptide-drug conjugates [J].Acta Pharm Sin B, 2023,13(9): 3659-3677., articleTitle=null, refAbstract=null), Reference(id=1329905935314694151, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG J, BAE H.Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment [J].Exp Mol Med, 2023, 55(9): 1996-2004., articleTitle=null, refAbstract=null), Reference(id=1329905935377608712, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=FU C, YU L F, MIAO Y X, et al.Peptide-drug conjugates(PDCs): a novel trend of research and development on targeted therapy, hype or hope [J].Acta Pharm Sin B,2023, 13(2): 498-516., articleTitle=null, refAbstract=null), Reference(id=1329905935444717577, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Z J, LI H X, GOU L T, et al.Antibody-drug conjugates: recent advances in payloads [J].Acta Pharm Sin B, 2023, 13(10): 4025-4059., articleTitle=null, refAbstract=null), Reference(id=1329905935520215050, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=DEAN T T, JELÚ-REYES J, ALLEN A L C, et al.Peptide-drug conjugates: an emerging direction for the next generation of peptide therapeutics [J].J Med Chem, 2024, 67(3): 1641-1661., articleTitle=null, refAbstract=null), Reference(id=1329905935578935307, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG A, SEISS K, LABORDE L, et al.Design, synthesis,and in vitro and in vivo evaluation of cereblon binding Bruton’s tyrosine kinase(BTK) degrader CD79b targeted antibody-drug conjugates [J].Bioconjug Chem, 2024, 35(2): 140-146., articleTitle=null, refAbstract=null), Reference(id=1329905935641849868, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=HONG K B, AN H C.Degrader-antibody conjugates: emerging new modality [J].J Med Chem, 2022, 66(1): 140-148., articleTitle=null, refAbstract=null), Reference(id=1329905935700570125, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=LEHMANN T, SCHNEIDER H, TONILLO J, et al.Welding PROxAb shuttles: a modular approach for generating bispecific antibodies via site-specific protein-protein conjugation [J].Bioconjug Chem, 2024, 35(6): 780-789., articleTitle=null, refAbstract=null), Reference(id=1329905935784456207, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=IZZO D, ASCIONE L, GUIDI L, et al.Innovative payloads for ADCs in cancer treatment: moving beyond the selective delivery of chemotherapy [J].Ther Adv Med Oncol, 2025,17: 17588359241309461., articleTitle=null, refAbstract=null), Reference(id=1329905935859953680, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN Y, YOU F, ZHU C C, et al.A novel TROP2-targeted immune stimulating antibody conjugate(ISAC) with potent anti-tumoral activtiy and accpetable safety [J].Cancer Res,2024, 84(6): 2718., articleTitle=null, refAbstract=null), Reference(id=1329905935918673937, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG C, ZHANG Y J, CHEN W J, et al.New-generation advanced PROTACs as potential therapeutic agents in cancer therapy [J].Mol Cancer, 2024, 23(1): 110., articleTitle=null, refAbstract=null), Reference(id=1329905935985782802, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=TSUCHIKAMA K, ANAMI Y, HA S Y, et al.Exploring the next generation of antibody-drug conjugates [J].Nat Rev Clin Oncol, 2024, 21(3): 203-223., articleTitle=null, refAbstract=null), Reference(id=1329905936052891667, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=GU Y L, WANG Z J, WANG Y X.Bispecific antibody drug conjugates: making 1+ 1> 2 [J].Acta Pharm Sin B, 2024,14(5): 1965-1986., articleTitle=null, refAbstract=null), Reference(id=1329905936115806228, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=SHANG C Z, YANG L, ZHANG J Y, et al.YH012, a novel bispecific anti-HER2 and TROP2 antibody-drug conjugate,exhibits potent antitumor efficacy [J].Cancer Res, 2022,82(12): 4256., articleTitle=null, refAbstract=null), Reference(id=1329905936178720789, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=NEIJSSEN J, CARDOSO R M F, CHEVALIER K M, et al.Discovery of amivantamab(JNJ-61186372), a bispecific antibody targeting EGFR and MET [J].J Biol Chemi, 2021,296: 100641., articleTitle=null, refAbstract=null), Reference(id=1329905936266801174, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=WALSH S J, BARGH J D, DANNHEIM F M, et al.Site-selective modification strategies in antibody-drug conjugates[J].Chem Soc Rev, 2021, 50(2): 1305-1353., articleTitle=null, refAbstract=null), Reference(id=1329905936333910039, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=XIONG M J, FAN B B, GAO X J, et al.An innovative site-specific dual-payload antibody drug conjugate(dpADC)combining a novel Topo1 inhibitor and an immune agonist delivers a strong immunogenic cell death(ICD) and antitumor response in vitro and in vivo [J].Cancer Res, 2023, 83(7): 2640., articleTitle=null, refAbstract=null), Reference(id=1329905936405213208, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=TANG C H, ZENG Y, ZHANG J X, et al.One-pot assembly of dual-site-specific antibody-drug conjugates via glycan remodeling and affinity-directed traceless conjugation [J].Bioconjug Chem, 2023, 4(4): 748-755., articleTitle=null, refAbstract=null), Reference(id=1329905936489099289, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU J, ZHAO X B, LI E, et al.A novel dual drug antibody-drug conjugate targeting hTrop2 has synergetic anti-tumor activity in solid tumor models [J].Cancer Res, 2024, 84(6): 3132., articleTitle=null, refAbstract=null), Reference(id=1329905936564596762, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=NILCHAN N, LI X L, PEDZISA L, et al.Dual-mechanistic antibody-drug conjugate via site-specific selenocysteine/cysteine conjugation [J].Antib ther, 2019, 2(4): 71-78., articleTitle=null, refAbstract=null), Reference(id=1329905936669454363, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU C, LILI K, JINLEI, et al.A novel “add-on” nanobody with an albumin-binding moiety based on the intelligent ligase-dependent conjugation(iLDC) technology: an innovative and versatile approach for next-generation radionuclide drug conjugates(RDCs) with enhanced pharmacokinetics and druggability [J].Cancer Res, 2024, 84(6_Supplement): 6032., articleTitle=null, refAbstract=null), Reference(id=1329905936736563228, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU L, LU Y L, LIU W, et al.Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice [J].Exp Hematol Oncol, 2024, 13(1): 26., articleTitle=null, refAbstract=null), Reference(id=1329905936795283485, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU F, ZHANG J W, YANG J Y, et al.225Ac-FL-020 is a novel PSMA-targeting radionuclide drug conjugate(RDC)with superior in vivo anti-tumor activity [J].Cancer Res,2024, 84(6_Suppl): 6023., articleTitle=null, refAbstract=null), Reference(id=1329905936879169566, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=XU S.Internalization, trafficking, intracellular processing and actions of antibody-drug conjugates [J].Pharm Res, 2015, 32(11): 3577-3583., articleTitle=null, refAbstract=null), Reference(id=1329905936937889824, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=SAMANTASINGHAR A, SUNILDUTT N P, AHMED F,et al.A comprehensive review of key factors affecting the efficacy of antibody drug conjugate [J].Biomed Pharmacother, 2023, 161: 114408., articleTitle=null, refAbstract=null), Reference(id=1329905936996610081, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=JOHNSON M L, BURNS T F, THOMPSON J R, et al.MYTX-011 in patients with previously treated locally advanced or metastatic NSCLC: initial dose escalation results in the phase 1 KisMET-01 study [J].J Clin Oncol, 2024,42(16_Suppl): 8558., articleTitle=null, refAbstract=null), Reference(id=1329905937059524642, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=TAPIA-GALISTEO A, COMPTE M, ÁLVAREZ-VALLINA L, et al.When three is not a crowd: trispecific antibodies for enhanced cancer immunotherapy [J].Theranostics, 2023,13(3): 1028-1041., articleTitle=null, refAbstract=null), Reference(id=1329905937126633507, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=ROSSIN R, VERSTEEGEN R M, WU J, et al.Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice [J].Nat Commun,2018, 9(1): 1484., articleTitle=null, refAbstract=null), Reference(id=1329905937189548068, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=XIAO D, LIU L Q, XIE F, et al.Azobenzene-based linker strategy for selective activation of antibody-drug conjugates[J].Angew Chem Int Ed Engl, 2024, 63(16): e202310318., articleTitle=null, refAbstract=null), Reference(id=1329905937252462629, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=LU N, WU J Q, TIAN M W, et al.Comprehensive review on the elaboration of payloads derived from natural products for antibody-drug conjugates [J].Eur J Med Chem, 2024, 268: 116233., articleTitle=null, refAbstract=null), Reference(id=1329905937311182886, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAI C C, CUI Y, GUO L, et al.Progress in the study of antibody-drug conjugates for the treatment of cervical cancer[J].Front Oncol, 2024, 14: 1395784., articleTitle=null, refAbstract=null), Reference(id=1329905937407651879, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=KAST F, SCHWILL M, STÜBER J C, et al.Engineering an anti-HER2 biparatopic antibody with a multimodal mechanism of action [J].Nature Commun, 2021, 12(1): 3790., articleTitle=null, refAbstract=null), Reference(id=1329905937474760744, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=MENON S, PARAKH S, SCOTT A M, et al.Antibody-drug conjugates: beyond current approvals and potential future strategies [J].Explor Target Antitumor Ther, 2022, 3(2): 252-277., articleTitle=null, refAbstract=null), Reference(id=1329905937546063913, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=GUAN H, WU Y, LI L, et al.Tumor neoantigens: novel strategies for application of cancer immunotherapy [J].Oncol Res, 2023, 31(4): 437-448., articleTitle=null, refAbstract=null), Reference(id=1329905937613172778, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=DEBON A, SIIROLA E, SNAJDROVA R.Enzymatic bioconjugation: a perspective from the pharmaceutical industry[J].JACS Au, 2023, 3(5): 1267-1283., articleTitle=null, refAbstract=null), Reference(id=1329905937684475947, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=SKIDMORE L, SAKAMURI S, KNUDSEN N A, et al.ARX788, a site-specific anti-HER2 antibody-drug conjugate,demonstrates potent and selective activity in HER2-low and T-DM1-resistant breast and gastric cancers [J].Mol Cancer Ther, 2020, 19(9): 1833-1843., articleTitle=null, refAbstract=null), Reference(id=1329905937759973420, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=MEZŐ G, GOMENA J, RANĐELOVIĆ I, et al.Oxime-linked peptide-daunomycin conjugates as good tools for selection of suitable homing devices in targeted tumor therapy: an overview [J].Int J Mol Sci, 2024, 25(3): 1864., articleTitle=null, refAbstract=null), Reference(id=1329905937827082285, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=CAO Y J, YU C F, WU K L, et al.Synthesis of precision antibody conjugates using proximity-induced chemistry [J].Theranostics, 2021, 11(18): 9107-9117., articleTitle=null, refAbstract=null), Reference(id=1329905937898385454, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=SHI W, LI W S, ZHANG J X, et al.One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates [J].Acta Pharm Sin B, 2022, 12(5): 2417-2428., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329905934320645115, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, awardId=tscy202306088, language=CN, fundingSource=山东省重点研发计划(泰山产业领军人才工程项目)(tscy202306088), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329905931900531655, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=1., ext=[AuthorCompanyExt(id=1329905931913114568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905931925697481, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南新时代生物技术有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905931988612042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=2., ext=[AuthorCompanyExt(id=1329905931997000651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905932009583564, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)]), AuthorCompany(id=1329905932110246861, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=3., ext=[AuthorCompanyExt(id=1329905932122829774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905932110246861, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000), AuthorCompanyExt(id=1329905932131218383, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905932110246861, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.鲁南制药集团股份有限公司,山东 临沂 276000)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.10.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.10.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2025.10.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2025.10.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1760025600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
抗体偶联药物的研究进展
赵丽丽 1, 2 , 朱玉强 1, 2 , 李朋 1, 2 , 朱中松 1, 2 , 刘忠 3, *
中国医药工业杂志 | 专论与综述 2025,56(10): 1243-1251
收起
收藏切换
中国医药工业杂志 |专论与综述 2025 , 56 (10) : 1243 -1251
抗体偶联药物的研究进展
全屏
[Author(id=1329905932198327249, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905932307379156, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932198327249, language=EN, stringName=Lili ZHAO, firstName=Lili, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400
2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905932391265237, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932198327249, language=CN, stringName=赵丽丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.鲁南新时代生物技术有限公司,山东 临沂 273400
2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400, bio={"content":"

赵丽丽,博士,高级研究员,从事蛋白药物的研究与开发。

"}, bioImg=null, bioContent=

赵丽丽,博士,高级研究员,从事蛋白药物的研究与开发。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905931900531655, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=1., ext=[AuthorCompanyExt(id=1329905931913114568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905931925697481, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南新时代生物技术有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905931988612042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=2., ext=[AuthorCompanyExt(id=1329905931997000651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905932009583564, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)])]), Author(id=1329905932458374103, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905932529677274, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932458374103, language=EN, stringName=Yuqiang ZHU, firstName=Yuqiang, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400
2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905932600980443, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932458374103, language=CN, stringName=朱玉强, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.鲁南新时代生物技术有限公司,山东 临沂 273400
2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905931900531655, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=1., ext=[AuthorCompanyExt(id=1329905931913114568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905931925697481, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南新时代生物技术有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905931988612042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=2., ext=[AuthorCompanyExt(id=1329905931997000651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905932009583564, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)])]), Author(id=1329905932672283613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905932756169696, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932672283613, language=EN, stringName=Peng LI, firstName=Peng, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400
2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905932823278561, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932672283613, language=CN, stringName=李朋, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.鲁南新时代生物技术有限公司,山东 临沂 273400
2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905931900531655, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=1., ext=[AuthorCompanyExt(id=1329905931913114568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905931925697481, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南新时代生物技术有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905931988612042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=2., ext=[AuthorCompanyExt(id=1329905931997000651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905932009583564, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)])]), Author(id=1329905932886193123, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905932961690598, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932886193123, language=EN, stringName=Zhongsong ZHU, firstName=Zhongsong, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400
2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905933024605159, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905932886193123, language=CN, stringName=朱中松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.鲁南新时代生物技术有限公司,山东 临沂 273400
2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905931900531655, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=1., ext=[AuthorCompanyExt(id=1329905931913114568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905931925697481, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931900531655, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南新时代生物技术有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905931988612042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=2., ext=[AuthorCompanyExt(id=1329905931997000651, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905932009583564, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905931988612042, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)])]), Author(id=1329905933087519721, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329905933163017195, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905933087519721, language=EN, stringName=Zhong LIU, firstName=Zhong, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905933234320364, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, authorId=1329905933087519721, language=CN, stringName=刘忠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.鲁南制药集团股份有限公司,山东 临沂 276000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905932110246861, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, xref=3., ext=[AuthorCompanyExt(id=1329905932122829774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905932110246861, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000), AuthorCompanyExt(id=1329905932131218383, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905931158139844, companyId=1329905932110246861, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.鲁南制药集团股份有限公司,山东 临沂 276000)])])]
赵丽丽1, 2, 朱玉强1, 2, 李朋1, 2, 朱中松1, 2, 刘忠3, *
作者信息
  • 1.鲁南新时代生物技术有限公司,山东 临沂 273400
  • 2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400
  • 3.鲁南制药集团股份有限公司,山东 临沂 276000
通讯作者:
刘忠,博士,高级研究员,从事蛋白药物的研究与开发。
作者简介:

赵丽丽,博士,高级研究员,从事蛋白药物的研究与开发。

Research Progress of Antibody Drug Conjugates
Lili ZHAO1, 2, Yuqiang ZHU1, 2, Peng LI1, 2, Zhongsong ZHU1, 2, Zhong LIU3, *
Affiliations
  • 1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400
  • 2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400
  • 3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000
出版时间: 2025-10-10 doi: 10.16522/j.cnki.cjph.2025.10.001
文章导航
收藏切换

抗体偶联药物(ADCs)是结合了单克隆抗体的高度靶向性和小分子毒素的强细胞毒性的新型抗肿瘤药,能在高效杀伤肿瘤细胞的同时,最大限度地减少对健康细胞的损伤并降低全身毒性。这种被称为“生物导弹”的新型抗肿瘤药正在引领恶性肿瘤靶向治疗的新时代。虽然已有三代ADCs应用于恶性肿瘤治疗,但仍需要进一步优化ADCs各组分来解决ADCs的稳定性、细胞毒性、耐药性等问题。本文总结了已获批上市和临床在研的ADCs,展望了下一代ADCs的创新方向,为利用ADCs技术推进恶性肿瘤的治疗和研究提供了思路。

抗肿瘤药  /  抗体偶联药物  /  前沿技术  /  稳定性  /  细胞毒性  /  耐药性  /  研究进展

Antibody-drug conjugates(ADCs) are novel antineoplastics that combine the high targeting specificity of monoclonal antibodies with the potent cytotoxicity of small-molecule toxins. By selectively delivering cytotoxic payloads to tumor cells, ADCs achieve effective tumor cell killing while minimizing damage to healthy cells and reducing systemic toxicity. These innovative agents, often referred to as “biological missile”, are leading a new era in targeted cancer therapy.Although three generations of ADCs have been applied to cancer treatment, further optimization of the components of ADCs is still required to address challenges such as stability, cytotoxicity, and drug resistance. This article summarizes the approved ADCs and those under clinical research, outlines innovative directions for next-generation ADCs, to provide insights for advancing research and development of novel cancer treatments using ADC technology.

antineoplastics  /  antibody-drug conjugate  /  frontier technology  /  stability  /  cytotoxicity  /  drug resistance  /  research progress
赵丽丽, 朱玉强, 李朋, 朱中松, 刘忠. 抗体偶联药物的研究进展. 中国医药工业杂志, 2025 , 56 (10) : 1243 -1251 . DOI: 10.16522/j.cnki.cjph.2025.10.001
Lili ZHAO, Yuqiang ZHU, Peng LI, Zhongsong ZHU, Zhong LIU. Research Progress of Antibody Drug Conjugates[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (10) : 1243 -1251 . DOI: 10.16522/j.cnki.cjph.2025.10.001
  • 山东省重点研发计划(泰山产业领军人才工程项目)(tscy202306088)
参考文献 引证文献
排序方式:
[1]
BAAH S, LAWS M, RAHMAN K M.Antibody-drug conjugates - a tutorial review [J].Molecules, 2021, 26(10): 2943.
[2]
MCKERTISH C M, KAYSER V.Advances and limitations of antibody drug conjugates for cancer [J].Biomedicines,2021, 9(8): 872.
[3]
TSUCHIKAMA K, AN Z Q.Antibody-drug conjugates: recent advances in conjugation and linker chemistries [J].Protein Cell, 2018, 9(1): 33-46.
[4]
JOHNSTON M C, SCOTT C J.Antibody conjugated nanoparticles as a novel form of antibody drug conjugate chemotherapy [J].Drug Discov Today Technol, 2018, 30: 63-69.
[5]
BECK A, GOETSCH L, DUMONTET C, et al.Strategies and challenges for the next generation of antibody-drug conjugates [J].Nat Rev Drug Discov, 2017, 16(5): 315-337.
[6]
BLACKHALL F, JAO K, GREILLIER L, et al.Efficacy and safety of rovalpituzumab tesirine compared with topotecan as second-line therapy in DLL3-high SCLC: results from the phase 3 TAHOE study [J].J Thorac Oncol, 2021, 16(9): 1547-1558.
[7]
LI J H, LIU L, ZHAO X H.Precision targeting in oncology: the future of conjugated drugs [J].Biomed Pharmacother,2024, 177: 117106.
[8]
HOFFMANN R M, COUMBE B G T, JOSEPHS D H, et al.Antibody structure and engineering considerations for the design and function of antibody drug conjugates [J].Oncoimmunology, 2018, 7(3): e1395127.
[9]
MAREI H E, CENCIARELLI C, HASAN A.Potential of antibody-drug conjugates(ADCs) for cancer therapy [J].Cancer Cell Int, 2022, 22(1): 255.
[10]
RUAN D Y, WU H X, MENG Q, et al.Development of antibody-drug conjugates in cancer: overview and prospects[J].Cancer Commun (Lond), 2024, 44(1): 3-22.
[11]
LIU Y T, NGUYEN A W, MAYNARD J A.Engineering antibodies for conditional activity in the solid tumor microenvironment [J].Curr Opin Biotechnol, 2022, 78: 102809.
[12]
GONG L M, ZHAO H M, LIU Y H, et al.Research advances in peptide-drug conjugates [J].Acta Pharm Sin B, 2023,13(9): 3659-3677.
[13]
YANG J, BAE H.Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment [J].Exp Mol Med, 2023, 55(9): 1996-2004.
[14]
FU C, YU L F, MIAO Y X, et al.Peptide-drug conjugates(PDCs): a novel trend of research and development on targeted therapy, hype or hope [J].Acta Pharm Sin B,2023, 13(2): 498-516.
[15]
WANG Z J, LI H X, GOU L T, et al.Antibody-drug conjugates: recent advances in payloads [J].Acta Pharm Sin B, 2023, 13(10): 4025-4059.
[16]
DEAN T T, JELÚ-REYES J, ALLEN A L C, et al.Peptide-drug conjugates: an emerging direction for the next generation of peptide therapeutics [J].J Med Chem, 2024, 67(3): 1641-1661.
[17]
ZHANG A, SEISS K, LABORDE L, et al.Design, synthesis,and in vitro and in vivo evaluation of cereblon binding Bruton’s tyrosine kinase(BTK) degrader CD79b targeted antibody-drug conjugates [J].Bioconjug Chem, 2024, 35(2): 140-146.
[18]
HONG K B, AN H C.Degrader-antibody conjugates: emerging new modality [J].J Med Chem, 2022, 66(1): 140-148.
[19]
LEHMANN T, SCHNEIDER H, TONILLO J, et al.Welding PROxAb shuttles: a modular approach for generating bispecific antibodies via site-specific protein-protein conjugation [J].Bioconjug Chem, 2024, 35(6): 780-789.
[20]
IZZO D, ASCIONE L, GUIDI L, et al.Innovative payloads for ADCs in cancer treatment: moving beyond the selective delivery of chemotherapy [J].Ther Adv Med Oncol, 2025,17: 17588359241309461.
[21]
CHEN Y, YOU F, ZHU C C, et al.A novel TROP2-targeted immune stimulating antibody conjugate(ISAC) with potent anti-tumoral activtiy and accpetable safety [J].Cancer Res,2024, 84(6): 2718.
[22]
WANG C, ZHANG Y J, CHEN W J, et al.New-generation advanced PROTACs as potential therapeutic agents in cancer therapy [J].Mol Cancer, 2024, 23(1): 110.
[23]
TSUCHIKAMA K, ANAMI Y, HA S Y, et al.Exploring the next generation of antibody-drug conjugates [J].Nat Rev Clin Oncol, 2024, 21(3): 203-223.
[24]
GU Y L, WANG Z J, WANG Y X.Bispecific antibody drug conjugates: making 1+ 1> 2 [J].Acta Pharm Sin B, 2024,14(5): 1965-1986.
[25]
SHANG C Z, YANG L, ZHANG J Y, et al.YH012, a novel bispecific anti-HER2 and TROP2 antibody-drug conjugate,exhibits potent antitumor efficacy [J].Cancer Res, 2022,82(12): 4256.
[26]
NEIJSSEN J, CARDOSO R M F, CHEVALIER K M, et al.Discovery of amivantamab(JNJ-61186372), a bispecific antibody targeting EGFR and MET [J].J Biol Chemi, 2021,296: 100641.
[27]
WALSH S J, BARGH J D, DANNHEIM F M, et al.Site-selective modification strategies in antibody-drug conjugates[J].Chem Soc Rev, 2021, 50(2): 1305-1353.
[28]
XIONG M J, FAN B B, GAO X J, et al.An innovative site-specific dual-payload antibody drug conjugate(dpADC)combining a novel Topo1 inhibitor and an immune agonist delivers a strong immunogenic cell death(ICD) and antitumor response in vitro and in vivo [J].Cancer Res, 2023, 83(7): 2640.
[29]
TANG C H, ZENG Y, ZHANG J X, et al.One-pot assembly of dual-site-specific antibody-drug conjugates via glycan remodeling and affinity-directed traceless conjugation [J].Bioconjug Chem, 2023, 4(4): 748-755.
[30]
ZHU J, ZHAO X B, LI E, et al.A novel dual drug antibody-drug conjugate targeting hTrop2 has synergetic anti-tumor activity in solid tumor models [J].Cancer Res, 2024, 84(6): 3132.
[31]
NILCHAN N, LI X L, PEDZISA L, et al.Dual-mechanistic antibody-drug conjugate via site-specific selenocysteine/cysteine conjugation [J].Antib ther, 2019, 2(4): 71-78.
[32]
LIU C, LILI K, JINLEI, et al.A novel “add-on” nanobody with an albumin-binding moiety based on the intelligent ligase-dependent conjugation(iLDC) technology: an innovative and versatile approach for next-generation radionuclide drug conjugates(RDCs) with enhanced pharmacokinetics and druggability [J].Cancer Res, 2024, 84(6_Supplement): 6032.
[33]
ZHOU L, LU Y L, LIU W, et al.Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice [J].Exp Hematol Oncol, 2024, 13(1): 26.
[34]
LIU F, ZHANG J W, YANG J Y, et al.225Ac-FL-020 is a novel PSMA-targeting radionuclide drug conjugate(RDC)with superior in vivo anti-tumor activity [J].Cancer Res,2024, 84(6_Suppl): 6023.
[35]
XU S.Internalization, trafficking, intracellular processing and actions of antibody-drug conjugates [J].Pharm Res, 2015, 32(11): 3577-3583.
[36]
SAMANTASINGHAR A, SUNILDUTT N P, AHMED F,et al.A comprehensive review of key factors affecting the efficacy of antibody drug conjugate [J].Biomed Pharmacother, 2023, 161: 114408.
[37]
JOHNSON M L, BURNS T F, THOMPSON J R, et al.MYTX-011 in patients with previously treated locally advanced or metastatic NSCLC: initial dose escalation results in the phase 1 KisMET-01 study [J].J Clin Oncol, 2024,42(16_Suppl): 8558.
[38]
TAPIA-GALISTEO A, COMPTE M, ÁLVAREZ-VALLINA L, et al.When three is not a crowd: trispecific antibodies for enhanced cancer immunotherapy [J].Theranostics, 2023,13(3): 1028-1041.
[39]
ROSSIN R, VERSTEEGEN R M, WU J, et al.Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice [J].Nat Commun,2018, 9(1): 1484.
[40]
XIAO D, LIU L Q, XIE F, et al.Azobenzene-based linker strategy for selective activation of antibody-drug conjugates[J].Angew Chem Int Ed Engl, 2024, 63(16): e202310318.
[41]
LU N, WU J Q, TIAN M W, et al.Comprehensive review on the elaboration of payloads derived from natural products for antibody-drug conjugates [J].Eur J Med Chem, 2024, 268: 116233.
[42]
ZHAI C C, CUI Y, GUO L, et al.Progress in the study of antibody-drug conjugates for the treatment of cervical cancer[J].Front Oncol, 2024, 14: 1395784.
[43]
KAST F, SCHWILL M, STÜBER J C, et al.Engineering an anti-HER2 biparatopic antibody with a multimodal mechanism of action [J].Nature Commun, 2021, 12(1): 3790.
[44]
MENON S, PARAKH S, SCOTT A M, et al.Antibody-drug conjugates: beyond current approvals and potential future strategies [J].Explor Target Antitumor Ther, 2022, 3(2): 252-277.
[45]
GUAN H, WU Y, LI L, et al.Tumor neoantigens: novel strategies for application of cancer immunotherapy [J].Oncol Res, 2023, 31(4): 437-448.
[46]
DEBON A, SIIROLA E, SNAJDROVA R.Enzymatic bioconjugation: a perspective from the pharmaceutical industry[J].JACS Au, 2023, 3(5): 1267-1283.
[47]
SKIDMORE L, SAKAMURI S, KNUDSEN N A, et al.ARX788, a site-specific anti-HER2 antibody-drug conjugate,demonstrates potent and selective activity in HER2-low and T-DM1-resistant breast and gastric cancers [J].Mol Cancer Ther, 2020, 19(9): 1833-1843.
[48]
MEZŐ G, GOMENA J, RANĐELOVIĆ I, et al.Oxime-linked peptide-daunomycin conjugates as good tools for selection of suitable homing devices in targeted tumor therapy: an overview [J].Int J Mol Sci, 2024, 25(3): 1864.
[49]
CAO Y J, YU C F, WU K L, et al.Synthesis of precision antibody conjugates using proximity-induced chemistry [J].Theranostics, 2021, 11(18): 9107-9117.
[50]
SHI W, LI W S, ZHANG J X, et al.One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates [J].Acta Pharm Sin B, 2022, 12(5): 2417-2428.
2025年第56卷第10期
35
9
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2025.10.001
  • 接收时间:2025-03-05
  • 首发时间:2026-11-18
  • 出版时间:2025-10-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-03-05
基金
山东省重点研发计划(泰山产业领军人才工程项目)(tscy202306088)
作者信息
    1.鲁南新时代生物技术有限公司,山东 临沂 273400
    2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400
    3.鲁南制药集团股份有限公司,山东 临沂 276000

通讯作者:

刘忠,博士,高级研究员,从事蛋白药物的研究与开发。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.10.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏